Researchers have identified a biomarker that predicts which stage II colon cancer patients may benefit from adjuvant chemotherapy to prevent a disease recurrence.
In Columbia's biomedical engineering department, engineers and physicians work together to solve problems and improve health care.
A stem cell capable of regenerating both bone and cartilage has been identified in bone marrow of mice.
Articles about hair regeneration, cocoa and memory, and flu forecasting are among the most-viewed research stories on CUMC websites.
Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss.
Scientists at the New York Stem Cell Foundation and CUMC have created the first disease-specific embryonic stem cell line using nuclear transfer technology.